Virginia Commonwealth University Massey Cancer Center opened a Phase II clinical study to see whether an FDA-cleared pain therapy device helps decrease pain in cancer patients. The study will examine the device’s effect on pain associated with chemotherapy-induced peripheral neuropathy … Continue reading →